Author:
Wander H. -E.,Nagel G. A.,Luig H.,Emrich D.
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Genetics (clinical),Drug Discovery,Molecular Medicine
Reference35 articles.
1. Ahmann FR, Pugh R (1985) Short-term treatment of poor prognosis metastatic breast cancer with three alternating chemotherapy regimens: a SWOG pilot study. Proc Am Soc Clin Oncol 4:C-264
2. Bezwoda WR, de Moor NG, Derman D, et al. (1979) Combination chemotherapy of metastatic breast cancer. Cancer 44:392–397
3. Blossey HC, Wander HE, Köbberling J, Nagel GA (1984) Pharmacokinetic and pharmacodynamic basis for the treatment of metastatic breast cancer with high-dose medroxyprogesterone acetate. Cancer 54:1208–1215S
4. Brambilla C, Delena M, Rossi A, et al. (1976) Response and survival in advanced breast cancer after two non-cross-resistant combinations. Br Med J I:801–804
5. Bull JM, Tormey DC, Li SH, et al. (1978) A randomized comparative trial of adriamycin vs methotrexate in combination drug therapy. Cancer 41:1649–1657